Embolic protection during saphenous vein graft interventions

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven therapy for preventing periprocedural myocardial infarction during SVG interventions, they are currently used in only a small proportion of eligible patients. In this review, we present an update on the clinical data and practical recommendations for using the currently available embolic protection devices during SVG interventions.

Original languageEnglish (US)
Pages (from-to)415-417
Number of pages3
JournalJournal of Invasive Cardiology
Volume21
Issue number8
StatePublished - Aug 2009

Fingerprint

Saphenous Vein
Embolic Protection Devices
Transplants
Myocardial Infarction
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Embolic protection during saphenous vein graft interventions. / Banerjee, Subhash; Brilakis, Emmanouil S.

In: Journal of Invasive Cardiology, Vol. 21, No. 8, 08.2009, p. 415-417.

Research output: Contribution to journalArticle

@article{9a1967b6816342efbf8dc011335720e6,
title = "Embolic protection during saphenous vein graft interventions",
abstract = "Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven therapy for preventing periprocedural myocardial infarction during SVG interventions, they are currently used in only a small proportion of eligible patients. In this review, we present an update on the clinical data and practical recommendations for using the currently available embolic protection devices during SVG interventions.",
author = "Subhash Banerjee and Brilakis, {Emmanouil S.}",
year = "2009",
month = "8",
language = "English (US)",
volume = "21",
pages = "415--417",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "8",

}

TY - JOUR

T1 - Embolic protection during saphenous vein graft interventions

AU - Banerjee, Subhash

AU - Brilakis, Emmanouil S.

PY - 2009/8

Y1 - 2009/8

N2 - Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven therapy for preventing periprocedural myocardial infarction during SVG interventions, they are currently used in only a small proportion of eligible patients. In this review, we present an update on the clinical data and practical recommendations for using the currently available embolic protection devices during SVG interventions.

AB - Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven therapy for preventing periprocedural myocardial infarction during SVG interventions, they are currently used in only a small proportion of eligible patients. In this review, we present an update on the clinical data and practical recommendations for using the currently available embolic protection devices during SVG interventions.

UR - http://www.scopus.com/inward/record.url?scp=69249137964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249137964&partnerID=8YFLogxK

M3 - Article

C2 - 19652257

AN - SCOPUS:69249137964

VL - 21

SP - 415

EP - 417

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 8

ER -